Back to articles

Updated guideline released on use of disease-modifying therapies for patients with MS


In April 2018, the American Academy of Neurology (AAN) published an updated guideline in Neurology on the use of disease-modifying agents for patients with multiple sclerosis (MS). The guideline focuses on who should start these therapies, which agents to initiate, switching between medications, and when to stop treatment.